The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Clinical Trials, Phase I as Topic.
Andrzej Jakubowiak
Connection Strength
0.199
Clinical Trials, Phase I as Topic
  1. Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies. Leuk Lymphoma. 2022 10; 63(10):2413-2421.
    View in: PubMed
    Score: 0.199
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.